Soleno Therapeutics tumbles despite Q3 earnings, revenue beat
NegativeFinancial Markets

Soleno Therapeutics saw a significant drop in its stock price despite reporting better-than-expected earnings and revenue for the third quarter. Investors reacted negatively, raising concerns about the company's future performance.
— Curated by the World Pulse Now AI Editorial System








